Selinexor Enhances Natural Killer Cell Function Against Multiple Myeloma Cells

被引:0
|
作者
Fisher, Jack G. [1 ]
Doyle, Amber D. P. [1 ]
Graham, Lara V. [1 ]
Forconi, Francesco [2 ]
Cragg, Mark S. [3 ,4 ]
Walker, Christopher J. [5 ]
Khakoo, Salim I. [1 ]
Blunt, Matthew D. [1 ]
机构
[1] Univ Southampton, Sch Clin & Expt Sci, Fac Med, Southampton, Hants, England
[2] Univ Southampton, Sch Canc Sci, Fac Med, Southampton, Hants, England
[3] Univ Southampton, Antibody & Vaccine Grp, Ctr Canc Immunol, Southampton, Hants, England
[4] Univ Southampton, Antibody & Vaccine Grp, Ctr Canc Immunol, Fac Med, Southampton, Hants, England
[5] Karyopharm Therapeut, Newton, MA USA
关键词
D O I
10.1182/blood-2023-179744
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] NATURAL KILLER CELL (FROM PRIMARY NK CELL CULTURES) MEDIATED KILLING OF MULTIPLE MYELOMA CELLS IN VITRO
    Binder, Thomas M. C.
    Hildebrandt, York
    Giffey, Christian
    Jungk, Karla
    Eiermann, Thomas H.
    Sierich, Heidi
    Kroeger, Nicolaus
    TISSUE ANTIGENS, 2014, 84 (01): : 161 - 162
  • [32] Natural Killer Cell Line YT Exerts Cytotoxicity Against CD86+ Myeloma Cells
    Harnack, Ulf
    Johnen, Heiko
    Pecher, Gabriele
    ANTICANCER RESEARCH, 2011, 31 (02) : 475 - 479
  • [33] Natural killer cells affect the natural course, drug resistance, and prognosis of multiple myeloma
    Zhang, Li
    Peng, Xiaohuan
    Ma, Tao
    Liu, Jia
    Yi, Zhigang
    Bai, Jun
    Li, Yanhong
    Li, Lijuan
    Zhang, Liansheng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [34] Natural killer cells are active against myeloma cells with loss of tumor suppressor genes
    Dashevsky, Olga
    Gandolfi, Sara
    Dufva, Olli
    Simoes, Ricardo de Matos
    Huuhtanen, Jani
    Barwick, Benjamin
    Shirasaki, Ryosuke
    Sheffer, Michal
    Culhane, Aedin
    Licht, Jonathan
    Liacos, Christine-Ivy
    Terpos, Evangelos
    Kastritis, Efstathios
    Dimopoulos, Meletios
    Vazquez, Francisca
    Boise, Lawrence
    Kankainen, Matti
    Mustjoki, Satu
    Mitsiades, Constantine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S135 - S136
  • [35] Conserved and Unique Pathways of Natural Killer Cell Resistance in Multiple Myeloma Cell Lines
    Merino, Aimee
    Mitra, Amit
    Davis, Zachary
    Miller, Ben
    Valamehr, Bob
    Goodridge, Jode
    Miller, Jeffrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S73 - S73
  • [36] Harnessing natural killer cell effector function against cancer
    Blunt, Matthew D.
    Khakoo, Salim, I
    IMMUNOTHERAPY ADVANCES, 2024, 4 (01):
  • [37] Natural killer cell alloreactive haploidentical stem cell transplantation for multiple myeloma patients
    Elssen, Catharina
    Wieten, Lotte
    Von dem Borne, Peter
    Meijer, Ellen
    Bos, Gerard
    BONE MARROW TRANSPLANTATION, 2019, 54 : 605 - 605
  • [38] Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells
    Zhen, Yong-Zhan
    Lin, Ya-Jun
    Liu, Xiu-Jun
    Shang, Bo-Yang
    Zhen, Yong-Su
    ANTI-CANCER DRUGS, 2013, 24 (06) : 609 - 616
  • [39] Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma
    Cho, Hyunsoo
    Kim, Kyung Hwan
    Lee, Hoyoung
    Kim, Chang Gon
    Chung, Haerim
    Choi, Yoon Seok
    Park, Su-Hyung
    Cheong, June-Won
    Min, Yoo Hong
    Shin, Eui-Cheol
    Kim, Jin Seok
    CLINICAL CANCER RESEARCH, 2021, 27 (10) : 2947 - 2958
  • [40] Oridonin enhances cytotoxic activity of natural killer cells against lung cancer
    Hwang, Tsong-Long
    Chang, Chuan-Hsin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122